Premium
High‐throughput flow cytometry compatible biosensor based on fluorogen activating protein technology
Author(s) -
Wu Yang,
Tapia Phillip H.,
Fisher Gregory W.,
Waggoner Alan S.,
Jarvik Jonathan,
Sklar Larry A.
Publication year - 2013
Publication title -
cytometry part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.316
H-Index - 90
eISSN - 1552-4930
pISSN - 1552-4922
DOI - 10.1002/cyto.a.22242
Subject(s) - flow cytometry , receptor , microbiology and biotechnology , confocal microscopy , fusion protein , function (biology) , cytometry , high throughput screening , chemistry , biology , biochemistry , recombinant dna , gene
Abstract Monitoring the trafficking of multiple proteins simultaneously in live cells is of great interest because many receptor proteins are found to function together with others in the same cell. However, existing fluorescent labeling techniques have restricted the mechanistic study of functional receptor pairs. We have expanded a hybrid system combining fluorogen‐activating protein (FAP) technology and high‐throughput flow cytometry to a new type of biosensor that is robust, sensitive, and versatile. This provides the opportunity to study multiple trafficking proteins in the same cell. Human beta2 adrenergic receptor (β2AR) fused with FAP AM2.2 and murine C‐C chemokines receptor type 5 fused with FAP MG13 was chosen for our model system. The function of the receptor and the binding between MG13 and fluorogen MG‐2p have been characterized by flow cytometry and confocal microscopy assays. The binding of fluorogen and the FAP pair is highly specific, while both FAP‐tagged fusion proteins function similarly to their wild‐type counterparts. The system has successfully served as a counter screen assay to eliminate false positive compounds identified in a screen against NIH Molecular Libraries Small Molecule Repository targeting regulators of the human β2AR. © 2013 International Society for Advancement of Cytometry